StonvexLoading…
StonvexStonvexStonvexCore line items from CMCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $39.64M | $37.68M | $39.06M | $33.43M |
Operating Income | $-39.08M | $-24.95M | $-50.23M | $7.08M |
Net Income | $-39.00M | $-25.18M | $-48.48M | $5.92M |
EPS (Diluted) | $-67.08 | $-431.43 | $-31.02 | $-1.11 |
Total Assets | $859.19M | $889.55M | $891.20M | $690.25M |
Total Liabilities | $592.94M | $562.49M | $514.43M | $312.52M |
Cash & Equivalents | $15.44M | $20.26M | $19.29M | $46.19M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 2.70M | 466.18K | 2.28M | 22.74M |